|
Inhaled steroids may not be enough for some children with asthma
May 23, 2007ATS 2007, SAN FRANCISCO-Some children may not be able to keep their asthma under control even if they consistently report using inhaled corticosteroids, a mainstay of asthma treatment, suggests a new study presented at the American Thoracic Society 2007 International Conference, on Wednesday, May 23.
The study of 914 children with mild to moderate asthma found that over a one-year period, children who reported consistent inhaled steroid use were 20% less likely to report having well-controlled asthma compared with those not using any inhaled steroids. This finding held even when the severity of the children's asthma was taken into account.
"There may be several reasons for our findings; It is possible that some children are genetically less responsive to steroids," says researcher Gregory Sawicki, M.D. of Children's Hospital in Boston. "In addition to issues of medication adherence and inability to completely control for differences in underlying asthma, severity can never be completely ruled out."
Several studies of adults with asthma have suggested that even rigorous use of inhaled steroids doesn't lead to well controlled asthma in all adults, Dr. Sawicki noted. "But this issue hasn't been looked at closely in children," he said. "Further studies are needed to see what is different about children who don't respond to steroids, to see if there is a way to predict whether a child will respond to inhaled steroids."
Of the 914 children in the study, inhaled steroids were recommended for 435 who had persistent asthma, meaning they had symptoms on a regular basis. Among children who weren't recommended for inhaled steroid treatment, most reported well-controlled asthma. Among those recommended for inhaled steroid treatment, 44% reported consistently using the medicine; 35% said they intermittently used the medicine and 21% said they didn't use it at all.
"The majority of children with mild asthma are less likely to have symptoms as they get older and may not need to be on daily steroids," Dr. Sawicki said. "The flip side is that if a child has poor asthma control, the parents and doctor need to make sure the child is adhering to their inhaled steroid treatment. But variation in response to inhaled steroids, as other medications, is well described."
The data comes from the Child Asthma Management Program Continuation Study (CAMPCS), one of the largest groups of children with mild to moderate asthma in the nation who have been followed over 10 years. "This study gives us a good sense of real-world practice in asthma management," Dr. Sawicki says. "The children's care is not directed by anyone in the study; it's an observation of what goes on when the children's care is directed by their own physicians."
American Thoracic Society
Several studies of adults with asthma have suggested that even rigorous use of inhaled steroids doesn't lead to well controlled asthma in all adults, Dr. Sawicki noted. "But this issue hasn't been looked at closely in children," he said. "Further studies are needed to see what is different about children who don't respond to steroids, to see if there is a way to predict whether a child will respond to inhaled steroids."
Of the 914 children in the study, inhaled steroids were recommended for 435 who had persistent asthma, meaning they had symptoms on a regular basis. Among children who weren't recommended for inhaled steroid treatment, most reported well-controlled asthma. Among those recommended for inhaled steroid treatment, 44% reported consistently using the medicine; 35% said they intermittently used the medicine and 21% said they didn't use it at all.
"The majority of children with mild asthma are less likely to have symptoms as they get older and may not need to be on daily steroids," Dr. Sawicki said. "The flip side is that if a child has poor asthma control, the parents and doctor need to make sure the child is adhering to their inhaled steroid treatment. But variation in response to inhaled steroids, as other medications, is well described."
The data comes from the Child Asthma Management Program Continuation Study (CAMPCS), one of the largest groups of children with mild to moderate asthma in the nation who have been followed over 10 years. "This study gives us a good sense of real-world practice in asthma management," Dr. Sawicki says. "The children's care is not directed by anyone in the study; it's an observation of what goes on when the children's care is directed by their own physicians."
American Thoracic Society
Inhaled Steroids News and Current Inhaled Steroids Events RSSStudy proves the co-pay connection in chronic disease
As 2008 begins, millions of Americans are having to dig deeper into their own pockets every time they refill a prescription or see a doctor.
Study finds COPD patients taking inhaled steroids are at greater risk for severe pneumonia
Patients with Chronic Obstructive Pulmonary Disease (COPD) are increasingly being prescribed inhaled corticosteroids to control exacerbations of the disease, but a new study finds that the anti-inflammatory drugs increase the chances that these patients will be hospitalized for pneumonia.
More pounds equals worse asthma?
A new study presented at the American Thoracic Society 2007 International Conference finds that obese people are significantly more likely to have persistent or severe persistent asthma than their thinner counterparts.
Stopping inhaled corticosteroid use causes no problems in cystic fibrosis patient users
In comparison to cystic fibrosis (CF) patients who regularly use inhaled corticosteroid, those who did not use these drugs for six months exhibited no positive or negative effects in terms of major disease factors.
Inhaled steroids preferred over cromolyn to treat asthma
Adults and children with asthma will breathe deeper and have better control over their asthma with inhaled corticosteroids than with the medicine cromolyn, according to a new review of recent studies comparing the two treatments.
Asthma inhalers adopted more slowly for minority patients and children
Inhaled steroid medications for asthma, which have greatly reduced the need for patients to be hospitalized with serious symptoms, were significantly less likely to be prescribed for minority patients and children during the years soon after their introduction.
Vitamin supplement could help treatment-resistant asthma
Asthma patients who don't respond to steroid treatment suffer repeated asthma attacks, and are at greater risk of dying from the condition.
Doubling of steroids before severe asthma attacks ineffective (p 271)
Recommendations to double inhaled steroids at the start of asthma attacks are challenged by research findings in this week's issue of THE LANCET. Doubling the dose of inhaled corticosteroid when asthma control deteriorates is widely advocated but is of unproven value. Tim Harrison from the department of respiratory medicine, Nottingham City Hospital, UK, and colleagues studied 390 asthma patients, deemed to be at risk of an asthma exacerbation. Patients monitored their asthma for up to one year and were instructed to add an extra inhaler (either steroid or placebo) for two weeks when their asthma control deteriorated. There was no statistically significant difference in the proportion of p
Imperial Scientist In World's Top 50 List
A UK asthma researcher has been named as a 'citation superstar', becoming one of the world's most cited researchers over the last 20 years. Professor Peter Barnes, from the National Heart and Lung Institute, a Division of the Faculty of Medicine at Imperial College London and based at the Royal Brompton Hospital has been listed as number forty in the world's top 50 most cited scientists according to the journal Science Watch. Since 1983, he has written 1311 papers, which have been cited 38,823 times by other scientists and researchers. Only five other scientists from the UK feature in the list, of which Professor Barnes is the only clinical scientist. Professor Barnes is a leading expert
Stepping down inhaled steroids can cut side effects
A ‘stepdown’ approach to reduce doses of inhaled steroids in patients with chronic asthma can cut the risk of side effects without compromising asthma control, say researchers in this week’s BMJ.
More Inhaled Steroids News Articles
| © 2008 BrightSurf.com |